All Stories

  1. Flipped script for gefitinib: A reapproved tyrosine kinase inhibitor for first-line treatment of epidermal growth factor receptor mutation positive metastatic nonsmall cell lung cancer

    Article • Journal of Oncology Pharmacy Practice, July 2016, SAGE Publications

    Mr Brian Stanley Bogdanowicz